New Edge Wealth, LLC First Trust Nyse Arca Biotechn Transaction History

New Edge Wealth, LLC

$6.58 Billion
Q3 2025

A detailed history of New Edge Wealth, LLC transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, New Edge Wealth, LLC holds 8,571 shares of FBT stock, worth $1.71 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,571

Previous 8,571 -0.0%

Holding current value

$1.71 Million

Previous $1.38 Million 11.14%

% of portfolio

0.02%

Previous 0.02%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$145.67 - $165.99 $85,945 - $97,934	-590 Reduced 6.44%	8,571 $1.38 Million
Q1 2025 May 09, 2025	SELL	$164.86 - $182.19 $64,625 - $71,418	-392 Reduced 4.1%	9,161 $1.56 Million
Q4 2024 Feb 04, 2025	BUY	$161.65 - $178.69 $638,032 - $705,289	3,947 Added 70.41%	9,553 $1.59 Million
Q3 2024 Nov 12, 2024	SELL	$152.39 - $172.91 $3.19 Million - $3.62 Million	-20,909 Reduced 78.86%	5,606 $963,000
Q2 2024 Aug 01, 2024	BUY	$141.52 - $156.4 $2.92 Million - $3.23 Million	20,650 Added 352.09%	26,515 $4.08 Million

Q1 2024 May 06, 2024	SELL	$145.08 - $160.46 $26,694 - $29,524	-184 Reduced 3.04%	5,865 $901,000
Q4 2023 Jan 29, 2024	SELL	$132.5 - $158.45 $145,617 - $174,136	-1,099 Reduced 15.37%	6,049 $956,000
Q3 2023 Nov 08, 2023	BUY	$145.69 - $157.89 $396,859 - $430,092	2,724 Added 61.57%	7,148 $1.05 Million
Q2 2023 Aug 09, 2023	BUY	$151.19 - $159.79 $668,864 - $706,910	4,424 New	4,424 $677,000

Others Institutions Holding FBT

# of Institutions

286

Shares Held

3.39M

Call Options Held

20.3K

Put Options Held

View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

More about FBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.

Account

New Edge Wealth, LLC First Trust Nyse Arca Biotechn Transaction History